19 Sep 2023

Patent opposition withdrawn

Poolbeg Pharma PLC (POLB:LON) | 3.2 0 (-3.1%) | Mkt Cap: 22.0m

- Karl Keegan
- 3 pages

POLB announced today announces that the opposition to one of its European patents (Immunomodulator I) that was filed by a third party is to be withdrawn. In the pharmaceutical industry it is not unusual for patents to be challenged. POLB had previously disclosed in September 2021 that the Immunomodulator I European patent had been opposed but this has now been resolved. We maintain our BUY recommendation and 21p PT.

Sign up to access

Get access to our full offering from over 30 providers

Patent opposition withdrawn

Poolbeg Pharma PLC (POLB:LON) | 3.2 0 (-3.1%) | Mkt Cap: 22.0m

Published: 19 Sep 2023
Author: Karl Keegan
Pages: 3

POLB announced today announces that the opposition to one of its European patents (Immunomodulator I) that was filed by a third party is to be withdrawn. In the pharmaceutical industry it is not unusual for patents to be challenged. POLB had previously disclosed in September 2021 that the Immunomodulator I European patent had been opposed but this has now been resolved. We maintain our BUY recommendation and 21p PT.